FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040896752> ?p ?o ?g. }

• W2040896752 endingPage "674" @default.
• W2040896752 startingPage "670" @default.
• W2040896752 abstract "One hundred twenty pathologically confirmed operable Stage III (T3N0–2) breast cancer patients were randomized to receive either postoperative radiotherapy or chemotherapy, or a combination of these, with or without levamisole immunotherapy. Radiotherapy was given to regional lymph node areas and chest wall. Chemotherapy consisted of 6 cycles of Adriamycin (doxorubicin) (45 mg/m2), vincristine (1.2 mg/m2) intravenously, and cyclophosphamide (200 mg/m2 for 5 days) perorally every 4 weeks. Peroral levamisole, 150 mg a day, 2 days weekly, was given as an immunotherapy. The 3-year results are described in this article. The effect of levamisole on the prognosis cannot be evaluated yet because of the short follow-up period. The disease-free survival was almost equal in each patient group, however, some benefit was achieved by levamisole (a shift of disease-free survival from 12 to 18 months). The patients receiving radiotherapy alone had the poorest prognosis: 68% had a recurrent tumor, and 57% were alive. In the chemotherapy group, the figures were 53% and 72%, respectively. Patients who received a combined treatment had the best prognosis: 13% had a recurrent tumor, and 90% survived 3 years. There was a statistically significant difference in the recurrence rate between any single therapy and the combined treatment (radiotherapy to combined treatment, P < 0.001, chemotherapy to combined treatment, P ± 0.01 chi-square test). In overall survival, a statistically significant difference was reached between radiotherapy and combination treatment groups (P < 0.01, chi-square test). Radiotherapy gave a good local control of the tumor, and chemotherapy decreased the number of metastases. The nonmetastatic axillary lymph node status and secondary amenorrhea or severe menstrual disturbances were of positive prognostic value. The side effects due to radiotherapy and chemotherapy were moderate and tolerable. The dose of Adriamycin had to be reduced only in four patients. All of the patients receiving chemotherapy had a transient total alopecia. Three of them had nonlethal arrhythmias, and one had skin rash. Levamisole was found very toxic with 9 cases of transient agranulocytosis, leading to the discontinuation of immunotherapy in 22 of 59 patients. Our results show that radiotherapy controls the tumor only locally and chemotherapy systematically, but the best patient-saving results are achieved with a combination of radiotherapy and chemotherapy. The disease-free and overall survival are statistically significant, and favor the combined therapy." @default.
• W2040896752 created "2016-06-24" @default.
• W2040896752 creator A5000688612 @default.
• W2040896752 creator A5018111990 @default.
• W2040896752 creator A5055489225 @default.
• W2040896752 creator A5069927650 @default.
• W2040896752 date "1984-01-01" @default.
• W2040896752 modified "2023-10-16" @default.
• W2040896752 title "Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer" @default.
• W2040896752 cites W1972637700 @default.
• W2040896752 cites W1982010436 @default.
• W2040896752 cites W1998948045 @default.
• W2040896752 cites W2001019367 @default.
• W2040896752 cites W2014358204 @default.
• W2040896752 cites W2044202393 @default.
• W2040896752 cites W2050319891 @default.
• W2040896752 cites W2062310355 @default.
• W2040896752 cites W2064551390 @default.
• W2040896752 cites W2069358438 @default.
• W2040896752 cites W2086324653 @default.
• W2040896752 cites W2132134852 @default.
• W2040896752 cites W267005183 @default.
• W2040896752 doi "https://doi.org/10.1002/1097-0142(1984)54:4<670::aid-cncr2820540414>3.0.co;2-7" @default.
• W2040896752 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6744203" @default.
• W2040896752 hasPublicationYear "1984" @default.
• W2040896752 type Work @default.
• W2040896752 sameAs 2040896752 @default.
• W2040896752 citedByCount "82" @default.
• W2040896752 countsByYear W20408967522014 @default.
• W2040896752 countsByYear W20408967522015 @default.
• W2040896752 countsByYear W20408967522018 @default.
• W2040896752 countsByYear W20408967522020 @default.
• W2040896752 countsByYear W20408967522021 @default.
• W2040896752 crossrefType "journal-article" @default.
• W2040896752 hasAuthorship W2040896752A5000688612 @default.
• W2040896752 hasAuthorship W2040896752A5018111990 @default.
• W2040896752 hasAuthorship W2040896752A5055489225 @default.
• W2040896752 hasAuthorship W2040896752A5069927650 @default.
• W2040896752 hasBestOaLocation W20408967521 @default.
• W2040896752 hasConcept C121608353 @default.
• W2040896752 hasConcept C126322002 @default.
• W2040896752 hasConcept C141071460 @default.
• W2040896752 hasConcept C143998085 @default.
• W2040896752 hasConcept C2776694085 @default.
• W2040896752 hasConcept C2776755627 @default.
• W2040896752 hasConcept C2777863537 @default.
• W2040896752 hasConcept C2779429289 @default.
• W2040896752 hasConcept C2781325985 @default.
• W2040896752 hasConcept C509974204 @default.
• W2040896752 hasConcept C530470458 @default.
• W2040896752 hasConcept C71924100 @default.
• W2040896752 hasConceptScore W2040896752C121608353 @default.
• W2040896752 hasConceptScore W2040896752C126322002 @default.
• W2040896752 hasConceptScore W2040896752C141071460 @default.
• W2040896752 hasConceptScore W2040896752C143998085 @default.
• W2040896752 hasConceptScore W2040896752C2776694085 @default.
• W2040896752 hasConceptScore W2040896752C2776755627 @default.
• W2040896752 hasConceptScore W2040896752C2777863537 @default.
• W2040896752 hasConceptScore W2040896752C2779429289 @default.
• W2040896752 hasConceptScore W2040896752C2781325985 @default.
• W2040896752 hasConceptScore W2040896752C509974204 @default.
• W2040896752 hasConceptScore W2040896752C530470458 @default.
• W2040896752 hasConceptScore W2040896752C71924100 @default.
• W2040896752 hasIssue "4" @default.
• W2040896752 hasLocation W20408967521 @default.
• W2040896752 hasLocation W20408967522 @default.
• W2040896752 hasOpenAccess W2040896752 @default.
• W2040896752 hasPrimaryLocation W20408967521 @default.
• W2040896752 hasRelatedWork W1482869986 @default.
• W2040896752 hasRelatedWork W1978070076 @default.
• W2040896752 hasRelatedWork W2036802760 @default.
• W2040896752 hasRelatedWork W2083438316 @default.
• W2040896752 hasRelatedWork W2111618869 @default.
• W2040896752 hasRelatedWork W2145349532 @default.
• W2040896752 hasRelatedWork W2234071437 @default.
• W2040896752 hasRelatedWork W2330662417 @default.
• W2040896752 hasRelatedWork W2342164759 @default.
• W2040896752 hasRelatedWork W2418155614 @default.
• W2040896752 hasVolume "54" @default.
• W2040896752 isParatext "false" @default.
• W2040896752 isRetracted "false" @default.
• W2040896752 magId "2040896752" @default.
• W2040896752 workType "article" @default.